ASP Isotopes Inc

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Boca Raton, FL.

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

WASHINGTON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”) today announced the closing of the previously announced underwritten public offering of shares of its common stock. ASP Isotopes sold 2,754,250 shares of its common stock, which reflects the exercise in full by the underwriter of its option to purchase up to 359,250 additional shares of common stock, at a public offering price of $6.75 per share, less underwriting discounts and commissions. The total gross proceeds to ASP Isotopes from the offering (before deducting the underwriting discounts and commissions and offering expenses) were $18.6 million.

ASP Isotopes Announces Closing of Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares

WASHINGTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”) today announced the pricing of the previously announced underwritten public offering of shares of its common stock. ASP Isotopes has agreed to sell an aggregate of 2,395,000 shares of its common stock at a public offering price of $6.75 per share. The gross proceeds to ASP Isotopes from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by ASP Isotopes, and without giving effect to any exercise of the underwriters' option to purchase additional shares, are expected to be approximately $16.2 million. In addition, ASP Isotopes has granted the underwriters a 30-day option to purchase up to 359,250 additional shares of common stock at the public offering price, less the underwriting discounts and commissions. All of the shares in the public offering are to be sold by ASP Isotopes. The offering is expected to close on or about November 4, 2024, subject to the satisfaction of customary closing conditions.

ASP Isotopes Announces Pricing of Public Offering of Common Stock

WASHINGTON, Oct. 31, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”) today announced that it has commenced an underwritten public offering of shares of its common stock. ASP Isotopes intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of its common stock sold in the offering. All of the shares in the offering are to be sold by ASP Isotopes. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

ASP Isotopes Announces Proposed Public Offering of Common Stock

TerraPower, the Bill Gates-founded nuclear-power firm, will back the planned construction of a facility for producing enriched uranium.

ASP Isotopes Stock Surges on Uranium-Plant Agreement With TerraPower

PureCycle Technologies

As of Oct. 30, 2024, two stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 2 Materials Stocks That May Collapse This Month

The Bill Gates' funded reactor company TerraPower and ASP Isotopes said on Wednesday they have struck a deal to produce a new fuel, now only made in commercial amounts in Russia, for an expected next generation of nuclear power plants.

Gates-backed reactor company, ASP Isotopes plan plant to make nuclear fuel

- Term sheet contemplates preparation of definitive documentation pursuant to which TerraPower would provide funding for the construction of a uranium enrichment facility and would purchase HALEU after the expected completion of the facility. - Term sheet contemplates preparation of definitive documentation pursuant to which TerraPower would provide funding for the construction of a uranium enrichment facility and would purchase HALEU after the expected completion of the facility.

ASP Isotopes Inc. enters into Term Sheet with TerraPower, LLC for Construction of a HALEU Production Facility

WASHINGTON--(BUSINESS WIRE)--ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it has entered into a term sheet with TerraPower, a nuclear innovation company and advanced nuclear energy developer, related to the construction of a uranium enrichment facility capable of producing High Assay Low-Enriched Uranium (.

ASP Isotopes Inc. Enters Into Term Sheet With TerraPower, LLC for Construction of a HALEU Production Facility

Mobilicom 

ORLANDO, FL / ACCESSWIRE / September 13, 2024 / RedChip Companies will air interviews with Mobilicom Ltd. (NASDAQ:MOB) and ASP Isotopes Inc. (NASDAQ:ASPI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, September 14, at 7 p.m.

Mobilicom and ASP Isotopes Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Inter & Co Inc

Urban-gro

Are you looking to invest some spare change and target high-upside stocks that could potentially turn your modest investment into life-changing returns? If so, it might be worth considering the following three picks.

3 Stocks to Buy That Could Turn Your Beer Money Into Champagne Showers

AST SpaceMobile

IonQ

Investors are always on the hunt for the next big thing. Much like the internet revolution and the current AI boom, savvy investors look to get in early on the ground floor of the next world-changing trend.

3 Stocks You Haven't Heard of That Could Be the Next Big Thing

OppFi

SOW GOOD INC

Micro-cap stocks often get a bad rap, and for good reason. Many of these penny stocks are highly speculative and risky bets that can quickly go south.

3 Micro-Cap Stocks Destined for Future Blue-Chip Status

ASP Isotopes (NASDAQ: ASPI ) stock is down on Friday after the development stage advanced materials company announced a proposed public offering for its shares. The company hasn't revealed the finer details of this offering just yet.

Why Is ASP Isotopes (ASPI) Stock Down 19% Today?

ASP Isotopes is a specialty materials company focusing on isotopes, with a unique separation technology that could help it become a major source of supply for the Western world. Given its medium-term topline trajectory, valuations don't look prohibitive. Despite promising growth prospects, ASPI faces financial risks due to ongoing losses, cash outflows, and the potential need for further funding, along with uncertainties around regulatory approval.

ASP Isotopes: Poised To Emerge As A Key Player In The Isotope Supply Chain

WASHINGTON, June 13, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the appointment of Heather Kiessling as its chief financial officer (CFO), effective as of July 1, 2024 (or such earlier date as may be mutually agreed), to support the Company's next pivotal phase of growth. Robert Ainscow, who currently serves as the Company's CFO and chief operating officer (COO), will continue to serve as the Company's COO, enabling him to focus his full time and attention on the Company's operations and strategic initiatives.

ASP Isotopes Inc. Enhances Executive Leadership Team with the Appointment of Heather Kiessling as Chief Financial Officer

ASP Isotopes is strategically positioned to tackle several critical industrial challenges through its cutting-edge proprietary technologies, Aerodynamic Separation and Quantum Laser Enrichment. ASPI's industrial business revolutionizes access to rare isotopes crucial for industries spanning from nuclear medicine to quantum computing and nuclear fuel. Quantum Leap Energy (QLE JV) is a pioneering entity focused on quantum enrichment and facilitates the direct recycling of nuclear tailings into High-Assay Low-Enriched Uranium.

ASP Isotopes: Sorting Isotopes Could Enrich Your Portfolio

WASHINGTON, April 11, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASPI,” or the “Company”), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes used in multiple industries, today released the following letter to stockholders from its Chairman and CEO, Paul Mann.

ASP Isotopes Issues Letter to Stockholders

The Company believes the structure of this transaction will result in substantially less fees, costs and dilution than may occur in alternative capital raising transactions, such as an underwritten offering or a private placement priced at a discount The Company believes the structure of this transaction will result in substantially less fees, costs and dilution than may occur in alternative capital raising transactions, such as an underwritten offering or a private placement priced at a discount

ASP Isotopes Inc. Enters Into Warrant Inducement Transaction for Approximately $5.5 Million in Gross Proceeds

The contract focuses on preliminary engineering design and planning for an enrichment facility for the production of next generation nuclear fuels, and has an aggregate contract value of up to $2 million The contract focuses on preliminary engineering design and planning for an enrichment facility for the production of next generation nuclear fuels, and has an aggregate contract value of up to $2 million

ASP Isotopes Inc. Enters Into a Contract with U.S.-Based Small Modular Reactor (SMR) Company for Project Focused on Engineering Design and Planning for Enrichment Facility for the Production of Advanced Nuclear Fuels

WASHINGTON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or “ASPI” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, announced today an increase to the size of the previously announced offering of convertible notes by its wholly-owned subsidiary, Quantum Leap Energy LLC ("QLE”).

ASP Isotopes Inc. Announces Increase in Offering Size of Convertible Notes by Quantum Leap Energy

WASHINGTON, Feb. 18, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or “ASPI” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, announced today its intention to commence an offering by its wholly-owned subsidiary, Quantum Leap Energy LLC ("QLE”), of up to US$20 million aggregate principal amount of QLE's convertible notes (the "Notes"), subject to market and other conditions (the "Notes Offering").

ASP Isotopes Inc. Announces Proposed Offering of Convertible Notes by Quantum Leap Energy

- ASP Isotopes plans to spin a portion of Quantum Leap Energy's common equity to ASP Isotopes' stockholders as of a future record date, in a tax efficient manner.

ASP Isotopes Inc. Provides Update on Plans to Spin-Out its Wholly Owned Subsidiary, Quantum Leap Energy

Inno Holdings Inc

ORLANDO, FL / ACCESSWIRE / January 19, 2024 / RedChip Companies will air interviews with INNO Holdings, Inc. (NASDAQ:INHD) and ASP Isotopes, Inc. (NASDAQ:ASPI) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, January 20, at 7 p.m. Eastern Time (ET).

INNO Holdings and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

XCel Brands

ORLANDO, FL / ACCESSWIRE / January 12, 2024 / RedChip Companies will air interviews with Xcel Brands, Inc. (NASDAQ:XELB) and ASP Isotopes, Inc. (NASDAQ:ASPI) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, January 13, at 7 p.m. Eastern Time (ET).

Xcel Brands and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

-Company and its North American commercial partner, RC14, commenced the processing of feedstock for enriched Carbon-14 during December 2023.

News for ASP Isotopes Inc Stock (ASPI)